Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the kidney biopsy market right now?

In recent times, the kidney biopsy market size has seen robust growth. From 2024 to 2025, it is predicted to grow from $2.14 billion to $2.27 billion, marking a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this growth during the historic period include an increase in chronic kidney diseases, growing awareness towards early diagnosis, a surge in the elderly population, advancement in healthcare infrastructure, improved government initiatives focused on kidney disease management, and heightened consciousness about kidney health.

How fast Is the kidney biopsy market expected to grow, and what’s its future value?

In the coming years, the kidney biopsy market size is projected to witness substantial growth, reaching $2.8 billion in 2029 with a compound annual growth rate (CAGR) of 5.4%. The growth in this period can be credited to factors such as the increasing prevalence of kidney related illnesses, escalating healthcare spending, growing consciousness about early diagnosis, growing elderly population, rising demand for procedures that are minimally invasive, as well as an increase in research activities. The forecast period is likely to see major trends such as enhancements in biopsy techniques, the adoption of minimally invasive procedures, advancements in imaging technologies, the incorporation of artificial intelligence for improved precision and technological innovations in biopsy tools.

Get your kidney biopsy market report here!

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

What are the leading drivers of growth in the kidney biopsy market?

The kidney biopsy market is predicted to expand due to the mounting occurrence of renal cancer. Renal cancer, marked by the uncontrolled multiplication of anomalous cells in the kidney, has seen an increase due to factors such as lifestyle changes, environmental pollutants, and improved detection methods leading to more diagnoses. A kidney biopsy is crucial in diagnosing and managing renal cancer as it verifies the existence of malignant cells, determines the severity of cancer, helps plan the therapy, monitors the treatment progress, and offers prognosis data. For example, Cancer Research UK, a renowned cancer research institution, anticipates that new kidney cancer instances will rise from roughly 16,300 in 2023 to nearly 21,900 in 2025. Thus, the kidney biopsy market growth is being pushed by the rising incidence of renal cancer.

What are the key segments defining the kidney biopsy market?

The kidney biopsy market covered in this report is segmented –

1) By Type: Percutaneous Biopsy, Surgical Biopsy

2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

3) By End-User: Hospitals And Clinics, Urology Centers, Tertiary Care Centers, Other End-Users

Subsegments:

1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy, MRI-Guided Biopsy

2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

Who are the key players steering the development of the kidney biopsy market?

Major companies operating in the kidney biopsy market are Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca, Medtronic, Siemens Healthcare Private Limited, Becton, Dickinson and Company, Stryker Healthcare, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Zimmer Biomet, Agilent Technologies Inc., Olympus Corporation, Hitachi High-Tech Corporation, Beckman Coulter Inc., B. Braun, Sysmex Corporation, Cook Medical, Bio-Rad Laboratories Inc., Integra LifeSciences Corporation, Merit Medical Systems, Leica Biosystems Nussloch GmbH, Argon Medical Devices Inc., BioGenex

What key trends are currently impacting the kidney biopsy market’s development?

Prominent organizations functioning in the kidney biopsy market are creating novel frameworks through the incorporation of artificial intelligence (AI) to augment diagnostic precision, make procedures more efficient, and boost patient outcomes. By honing image analysis, extending diagnostic assistance, facilitating in procedure planning, providing predictive metrics, and fostering advancements in kidney disease research, AI elevates kidney biopsy procedures. For instance, Aiosyn, a software firm based in the Netherlands, introduced the NephroPath platform in March 2024. The NephroPath platform leverages computational pathology algorithms to examine histological biomarkers present in kidney biopsies, identify tissue types, exact measurement of interstitial fibrosis, and accurate counting and evaluation of glomeruli. This AI-powered analysis assures uniform, comprehensive, and repeatable scoring of renal pathology biomarkers, thus solving the issues associated with traditional scoring techniques and observer bias.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16458

Which regions are most influential in expanding the kidney biopsy market?

North America was the largest region in the kidney biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Diabetic Kidney Disease Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Kidney Disease Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Kidney Cancer Diagnostics And Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/kidney-cancer-diagnostics-and-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: